Initial performance evaluation of the UniCel ® DxH 800 Coulter ® cellular analysis system

International Journal of Laboratory Hematology

Volumn 33, Issue 1, 2011, Pages 45-56

  Hedley, B D ^a   Keeney, M ^a   Chin Yee, I ^a   Brown, W ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Extreme leukocytosis; Hematology analyzer; Interference; NRBC; Platelet count; WBC

Indexed keywords

ARTICLE; AUTOANALYZER; BLOOD CELL COUNT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ERYTHROCYTE COUNT; FLOW CYTOMETRY; HUMAN; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOCYTOSIS; PRIORITY JOURNAL; RETICULOCYTE COUNT; THROMBOCYTE COUNT;

AUTOMATION, LABORATORY; BLOOD CELL COUNT; ERYTHROBLASTS; FLOW CYTOMETRY; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 78651091820     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2010.01239.x     Document Type: Article

References (31)

1. Aulesa C., Pastor I., Naranjo D., Piqueras J. & Galimany R. (2003) Validation of the Coulter LH 750 in a hospital reference laboratory. Laboratory Hematology 9, 15-28.
2. Aulesa C., Pastor I., Naranjo D. & Galimany R. (2004) Application of receiver operating characteristics curve (ROC) analysis when definitive and suspect morphologic flags appear in the New Coulter LH 750 Analyzer. Laboratory Hematology 10, 14-23.
3. Bodey G.P. (2009) The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. Journal of Antimicrobial Chemotherapy 63(Suppl 1), i3-i13.
4. Bourner G., Dhaliwal J. & Sumner J. (2005) Performance evaluation of the latest fully automated hematology analyzers in a large, commercial laboratory setting: a 4-way, side-by-side study. Laboratory Hematology 11, 285-297.
5. Brown W., Kaplan S., Keeney M., Johnson K., Wolfe N. & Chin-Yee I. (2001) Workflow improvement with random access and enhanced flagging on the New Coulter LH 750 Hematology Analyzer. Laboratory Hematology 7, 229-235.
6. Chin-Yee I., Keeney M., Johnson K., Brown W., Wolfe N. & Kaplan S. (2001) White blood cell flagging rates of the coulter LH 750 analyzer compared with the Coulter Gen•S Hematology Analyzer. Laboratory Hematology 7, 211-216.
7. Chin-Yee I., Brown W., Johnson K., Keeney M., Steele B., Wolfe N. & Kaplan S. (2002) Identification and enumeration of nucleated red blood cells on the coulter LH 750. Laboratory Hematology 8, 210-217.
8. Cosler L.E., Sivasubramaniam V., Agboola O., Crawford J., Dale D. & Lyman G.H. (2005) Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy. Value Health 8, 47-52.
9. Dranitsaris G., Rayson D., Vincent M., Chang J., Gelmon K., Sandor D. & Reardon G. (2008) Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model. American Journal of Clinical Oncology 31, 369-374.
10. Fernandez T., Domack L.B., Montes D., Pineiro R., Landrum E. & Vital E. (2001) Performance evaluation of the coulter LH 750 hematology analyzer. Laboratory Hematology 7, 217-228.
11. Ghys T., Malfait R. & J V.A.N.d.B. (2009) Performance evaluation of the Sysmex XS-1000i automated haematology analyser. International Journal of Laboratory Hematology 31, 560-566.
12. Hanseler E., Fehr J. & Keller H. (1996) Estimation of the lower limits of manual and automated platelet counting. American Journal of Clinical Pathology 105, 782-787.
13. Harrison P., Horton A., Grant D., Briggs C. & MacHin S. (2000) Immunoplatelet counting: a proposed new reference procedure. British Journal Haematology 108, 228-235.
14. Harrison P., Segal H., Briggs C., Murphy M. & Machin S. (2005) Impact of immunological platelet counting (by the platelet/RBC ratio) on haematological practice. Cytometry. Part B, Clinical Cytometry 67, 1-5.
15. ISLH (1994) International Council for Standardization in Hematology. Guidelines for evaluation of blood cell analyzers including those used for differential leukocyte and reticulocyte counting and cell marker application. Clinical and Laboratory Haematology, 16, 157-174.
16. Kaplan S.S., Johnson K. & Wolfe N. (2001) Validation of low platelet counts from coulter LH 750 and Coulter Gen•S Analyzers. Laboratory Hematology 7, 198-203.
17. Keeney M., Brown W. & Chin-Yee I. (2001) Platelet counts and flagging rates from the LH 750 hematology analyzer compared with the ICSH/ISLH platelet reference method and the Gen•S Hematology Analyzer. Laboratory Hematology 7, 204-210.
18. Kho A.N., Hui S., Kesterson J.G. & McDonald C.J. (2007) Which observations from the complete blood cell count predict mortality for hospitalized patients? Journal of Hospital Medicine 2, 5-12.
19. Koepke J.A., Van Assendelft O.W., Brindza L.J., Davis B., Fernandes B., Gewirtz A.S. & Rabinovitch A. (2007) Reference leukocyte (WBC) differential count (proportional) and evaluation of instrumental methods; approved standard, 2nd edn. Clinical and Laboratory Standards Institute, Pennsylvania.
20. La Porta A.D., Bowden A.S. & Barr S. (2002) Impact of the coulter LH 750 on productivity, turnaround time, and work flow in a core laboratory. Laboratory Hematology 8, 218-224.
21. Muller R., Mellors I., Johannessen B., Aarsand A.K., Kiefer P., Hardy J., Kendall R. & Scott C.S. (2006) European multi-center evaluation of the Abbott Cell-Dyn sapphire hematology analyzer. Laboratory Hematology 12, 15-31.
22. Navarro J.T., Hernandez J.A., Ribera J.M., Sancho J.M., Oriol A., Pujol M., Milla F. & Feliu E. (1998) Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10, 000/microL versus 20, 000/microL. Haematologica 83, 998-1000.
23. Nevo S., Fuller A.K., Hartley E., Borinsky M.E. & Vogelsang G.B. (2007) Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. Transfusion 47, 801-812.
24. Oka S., Muroi K., Mori M., Matsuyama T., Fujiwara S., Oh I., Ono Y., Kikuchi S., Sato K., Ueda M., Toshima M., Ozaki K., Takatoku M., Nagai T. & Ozawa K. (2007) Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy. Internal Medicine 46, 1669-1670.
25. Richardson Jones A., Cornbleet J., Houwen B., Van Hove L., Koepke J.A., Simson E., Swaim W.R. & Van Assendelft O.W. (1996) Performance goals for the internal quality control of multichannel hematology analyzers; approved standard. Clinical and Laboratory Standards Institute, Pennsylvania.
26. Sagmeister M., Oec L. & Gmur J. (1999) A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. Blood 93, 3124-3126.
27. Schwartz S.O. & Stansbury F. (1954) Significance of nucleated red blood cells in periperal blood: analysis of 1, 496 cases. JAMA 154, 1339-1340.
28. Segal H.C., Briggs C., Kunka S., Casbard A., Harrison P., Machin S.J. & Murphy M.F. (2005) Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. British Journal Haematology 128, 520-525.
29. Slichter S.J. (2007) Platelet transfusion therapy. Hematology/oncology Clinics of North America 21, 697-729.
30. Springer W., von Ruecker A. & Dickerhoff R. (1998) Difficulties in determining prophylactic transfusion thresholds of platelets in leukemia patients. Blood 92, 2183-2184.
31. Stachon A., Sondermann N., Imohl M. & Krieg M. (2002) Nucleated red blood cells indicate high risk of in-hospital mortality. Journal of Laboratory and Clinical Medicine 140, 407-412.